tebu-bio is a European company specialised in providing innovative reagents and laboratory services in Life Sciences

Need an answer now?

Give us a call

Leave a message, we'll get back to you


Product added to your basket !

Continue your visit View your basket
384reactions EUR 1205

Outsource this assay to our lab

Ask here

Contact us

Spike S1 B.1.617.1; SARS-CoV-2) ACE2 TR-FRET Assay

Product name
Spike S1 B.1.617.1; SARS-CoV-2) ACE2 TR-FRET Assay
Catalog number
78283 (384reactions)
The Spike S1 (B.1.617.1; Kappa Variant) (SARS-CoV-2): ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between Spike S1 (B.1.617.1) (SARS-CoV-2) and human ACE2 in a homogeneous 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, and the dye-labeled acceptor for one hour. Then the TR-FRET signal is measured using a fluorescence reader capable of measuring Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET).
Synonyms: coronavirus, SARS-CoV-2 inhibition kit, ACE2 inhibition kit, SARS TR-FRET kit, ACE2 homogenous kit, covid, covid-19, covid19, Sars-cov-2, sars cov 2, B16171, B.1.617.1 Variant, Kappa Variant, Kappa assay kit 
BPS Bioscience
Product category
Assays & Kits
Product sub category
Functional Assays
Biological activity
Shipment info
Dry Ice
Nacres Codification


To access the protocol, please provide your email address :